Physician profile
Taylor Smith
NPI 1902502610
$876.20
in general payments reported to CMS, 2019-2025
14 companies · $758 in 2025
The $758 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.62 · 2024: $106 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.59 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $144.33 | 2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $142.91 | 2025 | Erleada |
| Abbvie INC. | $99.12 | 2025 | |
| Seagen INC. | $84.99 | 2025 | |
| Olympus America INC. | $72.40 | 2025 | Itind System |
| Stryker Corporation | $60.12 | 2024 | Procuity |
| Pfizer INC. | $55.39 | 2025 | |
| Immunitybio, INC. | $53.53 | 2025 | |
| Tris Pharma INC | $46.32 | 2024 | Dyanavel Xr |
| Urogen Pharma, INC. | $31.52 | 2025 | |
| Blue Earth Diagnostics | $28.94 | 2025 | Posluma |
| Shockwave Medical, INC | $25.94 | 2025 | |
| Merck Sharp & Dohme LLC | $19.07 | 2025 | Keytruda |
| Organon LLC | $11.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.